| scholarly article | Q13442814 |
| P50 | author | Stefano Del Prato | Q41467287 |
| Roberto Miccoli | Q57207465 | ||
| Carmen Fotino | Q57528501 | ||
| Laura Pucci | Q59205277 | ||
| Giuseppe Penno | Q87777479 | ||
| Daniela Lucchesi | Q87777481 | ||
| P2093 | author name string | Giovanni Pellegrini | |
| Ennia Pardini | |||
| Stefano Triscornia | |||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | patient | Q181600 |
| P304 | page(s) | 480-488 | |
| P577 | publication date | 2007-01-26 | |
| P1433 | published in | Clinical Chemistry | Q849687 |
| P1476 | title | Cystatin C and estimates of renal function: searching for a better measure of kidney function in diabetic patients | |
| P478 | volume | 53 |
| Q33708360 | Application of "omics" to prion biomarker discovery |
| Q57070928 | Association Between Increased Levels of Cystatin C and the Development of Cardiovascular Events or Mortality: A Systematic Review and Meta-Analysis |
| Q92720450 | Association between 24-hour diastolic blood pressure and renal function in patients receiving treatment for essential hypertension |
| Q58562028 | Association between Serum Cystatin C and Vascular Complications in Type 2 Diabetes Mellitus without Nephropathy |
| Q40692957 | Association between serum cystatin C levels and the severity or potential risk factors of acute ischemic stroke |
| Q47914885 | Can admission serum cystatin C level be an early marker subclinical acute kidney injury in critical care patients? |
| Q26822369 | Chronic kidney disease screening methods and its implication for Malaysia: an in depth review |
| Q97873912 | Clinical Accuracy of Average Creatinine and Cystatin-C-Based Estimated GFR in Japanese Living Renal Transplantation Donors |
| Q34769036 | Clinical evaluation of serum cystatin C and creatinine in patients with chronic kidney disease: a meta-analysis |
| Q35841197 | Clinical utility of creatinine- and cystatin C-based definition of renal function for risk prediction of primary cardiovascular events in patients with diabetes |
| Q48357429 | Comparative study of radioprotective effects of selenium nanoparticles and sodium selenite in irradiation-induced nephropathy of mice model |
| Q92637823 | Comparison of Serum Cystatin C and Creatinine Levels among Individuals with Persisting Proteinuria in Farming Communities of Rural Sri Lanka |
| Q45936050 | Comparisons of cystatin C with creatinine for evaluation of renal function in chronic kidney disease. |
| Q37616631 | Contrast-induced nephropathy in aged critically ill patients |
| Q59101867 | Cystatin C and Its Role in Patients with Type 1 and Type 2 Diabetes Mellitus |
| Q46157359 | Cystatin C and cardiovascular mortality in patients with coronary artery disease and normal or mildly reduced kidney function: results from the AtheroGene study |
| Q34539983 | Cystatin C as an early biomarker of nephropathy in patients with type 2 diabetes |
| Q36345739 | Cystatin C identifies patients with stable chronic heart failure at increased risk for adverse cardiovascular events |
| Q33517129 | Cystatin C is downregulated in prostate cancer and modulates invasion of prostate cancer cells via MAPK/Erk and androgen receptor pathways |
| Q36869663 | Cystatin C--a paradigm of evidence based laboratory medicine. |
| Q37856794 | Cystatin C: a step forward in assessing kidney function and cardiovascular risk |
| Q37313436 | Cystatin C: current position and future prospects |
| Q39127610 | Diagnostic Accuracy of Serum Cystatin C for the Evaluation of Renal Dysfunction in Diabetic Patients: A Meta-Analysis |
| Q38088843 | Diagnostic biomarkers of diabetic nephropathy. |
| Q63430760 | Dietary intake of cod protein beneficially affects concentrations of urinary markers of kidney function and results in lower urinary loss of amino acids in obese Zucker fa/fa rats |
| Q43280925 | Different equations to combine creatinine and cystatin C to predict GFR. Arithmetic mean of existing equations performs as well as complex combinations. |
| Q39283479 | Discrepancy between cystatin C and creatinine points leading to a diagnosis of postrenal acute kidney injury and its reversibility: three case reports |
| Q46573006 | Early detection of diabetic nephropathy |
| Q35692447 | Early renal function decline in type 2 diabetes |
| Q28742534 | Effects of DPP-4 inhibitors on the heart in a rat model of uremic cardiomyopathy |
| Q61196609 | Elevated levels of renal and circulating Nop-7-associated 2 (NSA2) in rat and mouse models of diabetes, in mesangial cells in vitro and in patients with diabetic nephropathy |
| Q43534627 | Elevated serum cystatin C in severe OSA younger men without complications |
| Q35875301 | Estimated Glomerular Filtration Rate (eGFR): A Serum Creatinine-Based Test for the Detection of Chronic Kidney Disease and its Impact on Clinical Practice |
| Q41886073 | Estimating glomerular filtration rate in diabetes using serum cystatin C. |
| Q26860026 | Estimating glomerular filtration rate in older people |
| Q34152092 | Estimation of Glomerular Filtration Rate Based on Serum Cystatin C versus Creatinine in a Uruguayan Population. |
| Q50643798 | Evaluation of creatinine-based and cystatin C-based equations for estimation of glomerular filtration rate in type 1 diabetic patients. |
| Q51139349 | Evaluation of methods based on creatinine and cystatin C to estimate glomerular filtration rate in chronic kidney disease. |
| Q37901050 | Glomerular filtration rate estimation: performance of serum cystatin C-based prediction equations |
| Q37591529 | Glomerular filtration rate measurement and prediction equations. |
| Q37174066 | Improvement of cisplatin-related renal dysfunction by synthetic ghrelin: a prospective randomised phase II trial |
| Q85029604 | Insufficient performance of serum cystatin C as a biomarker for acute kidney injury of postrenal etiology |
| Q42587254 | Is Cystatin C an Important Prognostic Marker Independent of Renal Function? |
| Q35966409 | Markers of renal function tests |
| Q45573743 | Multiple marker approach to risk stratification in patients with stable coronary artery disease |
| Q88668007 | Normoalbuminuric chronic kidney disease in type 1 diabetes: is it real and is it serious? Reply to Rigalleau V, Blanco L, Alexandre L et al [letter] |
| Q34559347 | Pharmacokinetics of renally excreted drug dexpramipexole in subjects with impaired renal function |
| Q34073435 | Reference values for serum creatinine in children younger than 1 year of age. |
| Q35915967 | Relationship between High Serum Cystatin C Levels and the Risk of Gestational Diabetes Mellitus |
| Q37838428 | Reno-cerebrovascular disease: linking the nephron and neuron |
| Q33766242 | Risk factors for cardiovascular mortality in patients with systemic lupus erythematosus, a prospective cohort study |
| Q33962633 | Role of cystatin C in renal damage and the optimum cut-off point of renal damage among patients with type 2 diabetes mellitus |
| Q36263044 | Serum cystatin C as a marker to identify patients with moderately impaired renal function |
| Q43465192 | Signal transduction disturbance related to hepatocarcinogenesis in mouse by prolonged exposure to Nanjing drinking water |
| Q36621001 | The Association of Serum Cystatin C with Glycosylated Hemoglobin in Korean Adults. |
| Q90333711 | The Error of Estimated GFR in Type 2 Diabetes Mellitus |
| Q38121765 | The applicability of eGFR equations to different populations. |
| Q51366700 | The effects of proteinuria on urinary cystatin-C and glomerular filtration rate calculated by serum cystatin-C. |
| Q35025281 | Utility of serum creatinine/cystatin C ratio in diagnosis of postrenal acute kidney injury |
| Q46085999 | Validation of a new plasma cystatin C-based formula and the Modification of Diet in Renal Disease creatinine-based formula for determination of glomerular filtration rate. |
Search more.